A detailed history of Russell Investments Group, Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 1,055,257 shares of ABT stock, worth $121 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,055,257
Previous 809,981 30.28%
Holding current value
$121 Million
Previous $84.2 Million 42.94%
% of portfolio
0.18%
Previous 0.14%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$100.07 - $118.13 $24.5 Million - $29 Million
245,276 Added 30.28%
1,055,257 $120 Million
Q2 2024

Aug 08, 2024

BUY
$100.73 - $112.44 $195,013 - $217,683
1,936 Added 0.24%
809,981 $84.2 Million
Q1 2024

May 08, 2024

BUY
$109.52 - $120.96 $5.08 Million - $5.61 Million
46,366 Added 6.09%
808,045 $91.8 Million
Q4 2023

Feb 05, 2024

SELL
$90.19 - $110.4 $5.86 Million - $7.17 Million
-64,954 Reduced 7.86%
761,679 $83.8 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $7.68 Million - $9.21 Million
-80,352 Reduced 8.86%
826,633 $80.1 Million
Q2 2023

Aug 10, 2023

SELL
$100.78 - $112.29 $15.7 Million - $17.5 Million
-155,924 Reduced 14.67%
906,985 $98.9 Million
Q1 2023

May 09, 2023

SELL
$96.86 - $114.01 $5.18 Million - $6.09 Million
-53,447 Reduced 4.79%
1,062,909 $108 Million
Q4 2022

Feb 08, 2023

SELL
$95.06 - $111.52 $3.07 Million - $3.6 Million
-32,286 Reduced 2.81%
1,116,356 $123 Million
Q3 2022

Nov 04, 2022

SELL
$96.76 - $112.03 $2.67 Million - $3.1 Million
-27,629 Reduced 2.35%
1,148,642 $111 Million
Q2 2022

Jul 29, 2022

BUY
$102.07 - $123.37 $3.65 Million - $4.42 Million
35,796 Added 3.14%
1,176,271 $128 Million
Q1 2022

May 05, 2022

BUY
$114.02 - $139.04 $8.16 Million - $9.95 Million
71,560 Added 6.69%
1,140,475 $135 Million
Q4 2021

Jan 21, 2022

BUY
$115.53 - $141.46 $13.9 Million - $17 Million
120,032 Added 12.65%
1,068,915 $150 Million
Q3 2021

Nov 08, 2021

SELL
$116.66 - $129.06 $9.06 Million - $10 Million
-77,671 Reduced 7.57%
948,883 $112 Million
Q2 2021

Aug 04, 2021

SELL
$105.79 - $124.53 $18.6 Million - $21.9 Million
-175,882 Reduced 14.63%
1,026,554 $119 Million
Q1 2021

May 10, 2021

SELL
$108.84 - $128.23 $8.11 Million - $9.56 Million
-74,558 Reduced 5.84%
1,202,436 $144 Million
Q4 2020

Feb 08, 2021

SELL
$105.0 - $114.42 $11.6 Million - $12.7 Million
-110,572 Reduced 7.97%
1,276,994 $140 Million
Q3 2020

Nov 09, 2020

SELL
$91.64 - $111.29 $63,506 - $77,123
-693 Reduced 0.05%
1,387,566 $151 Million
Q2 2020

Aug 05, 2020

SELL
$76.57 - $98.0 $7.96 Million - $10.2 Million
-103,909 Reduced 6.96%
1,388,259 $127 Million
Q1 2020

May 06, 2020

SELL
$62.82 - $91.86 $45 Million - $65.9 Million
-717,108 Reduced 32.46%
1,492,168 $118 Million
Q4 2019

Jan 29, 2020

SELL
$78.51 - $87.4 $35.6 Million - $39.6 Million
-453,141 Reduced 17.02%
2,209,276 $192 Million
Q3 2019

Nov 01, 2019

SELL
$81.84 - $88.74 $427,286 - $463,311
-5,221 Reduced 0.2%
2,662,417 $223 Million
Q2 2019

Aug 09, 2019

SELL
$72.88 - $85.0 $12.9 Million - $15.1 Million
-177,364 Reduced 6.23%
2,667,638 $224 Million
Q1 2019

May 13, 2019

BUY
$66.22 - $80.06 $27 Million - $32.6 Million
407,527 Added 16.72%
2,845,002 $227 Million
Q4 2018

Feb 11, 2019

BUY
$65.56 - $74.27 $38.7 Million - $43.8 Million
589,655 Added 31.91%
2,437,475 $176 Million
Q3 2018

Oct 26, 2018

BUY
$60.81 - $73.36 $10.6 Million - $12.8 Million
173,801 Added 10.38%
1,847,820 $136 Million
Q2 2018

Aug 08, 2018

SELL
$57.57 - $63.54 $6.74 Million - $7.44 Million
-117,119 Reduced 6.54%
1,674,019 $102 Million
Q1 2018

May 11, 2018

SELL
$56.27 - $63.62 $24 Million - $27.1 Million
-426,643 Reduced 19.24%
1,791,138 $107 Million
Q4 2017

Feb 06, 2018

BUY
$53.68 - $57.47 $8.01 Million - $8.58 Million
149,283 Added 7.22%
2,217,781 $127 Million
Q3 2017

Nov 07, 2017

BUY
$48.06 - $53.64 $99.4 Million - $111 Million
2,068,498
2,068,498 $110 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.